272 related articles for article (PubMed ID: 28506209)
21. Antibody responses following vaccination versus infection in a porcine circovirus-type 2 (PCV2) disease model show distinct differences in virus neutralization and epitope recognition.
Trible BR; Ramirez A; Suddith A; Fuller A; Kerrigan M; Hesse R; Nietfeld J; Guo B; Thacker E; Rowland RR
Vaccine; 2012 Jun; 30(27):4079-85. PubMed ID: 22521847
[TBL] [Abstract][Full Text] [Related]
22. PCV cap proteins fused with calreticulin expressed into polymers in Escherichia coli with high immunogenicity in mice.
Liu C; Liu Y; Feng H; Zhao B; Chen Y; Huang H; Wang P; Deng R; Zhang G
BMC Vet Res; 2020 Aug; 16(1):313. PubMed ID: 32854700
[TBL] [Abstract][Full Text] [Related]
23. Early antibody responses map to non-protective, PCV2 capsid protein epitopes.
Ilha M; Nara P; Ramamoorthy S
Virology; 2020 Jan; 540():23-29. PubMed ID: 31734380
[TBL] [Abstract][Full Text] [Related]
24. Incorporation of ORF2 from Porcine Circovirus Type 2(PCV2) into genetically encoded nanoparticles as a novel vaccine using a self-aggregating peptide.
Zepeda-Cervantes J; Cruz-Reséndiz A; Sampieri A; Carreón-Nápoles R; Sánchez-Betancourt JI; Vaca L
Vaccine; 2019 Mar; 37(14):1928-1937. PubMed ID: 30824359
[TBL] [Abstract][Full Text] [Related]
25. Construction and immunogenicity of a recombinant pseudorabies virus co-expressing porcine circovirus type 2 capsid protein and interleukin 18.
Zheng LL; Guo XQ; Zhu QL; Chao AJ; Fu PF; Wei ZY; Wang SJ; Chen HY; Cui BA
Virus Res; 2015 Apr; 201():8-15. PubMed ID: 25701744
[TBL] [Abstract][Full Text] [Related]
26. Oral vaccination with attenuated Salmonella enterica serovar Typhimurium expressing Cap protein of PCV2 and its immunogenicity in mouse and swine models.
Xu XG; Zhao HN; Zhang Q; Ding L; Li ZC; Li W; Wu HY; Chuang KP; Tong DW; Liu HJ
Vet Microbiol; 2012 Jun; 157(3-4):294-303. PubMed ID: 22326539
[TBL] [Abstract][Full Text] [Related]
27. Comparison of Immune Responses to the PCV2 Replicase-Capsid and Capsid Virus-Like Particle Vaccines in Mice.
Jung BK; Kim HR; Lee YH; Jang H; Chang KS
J Microbiol Biotechnol; 2019 Mar; 29(3):482-488. PubMed ID: 30609882
[TBL] [Abstract][Full Text] [Related]
28. T lymphocyte epitope mapping of porcine circovirus type 2.
Stevenson LS; Gilpin DF; Douglas A; McNeilly F; McNair I; Adair BM; Allan GM
Viral Immunol; 2007 Sep; 20(3):389-98. PubMed ID: 17931109
[TBL] [Abstract][Full Text] [Related]
29. Expression of the capsid protein of porcine circovirus type 2 in Lactococcus lactis for oral vaccination.
Wang K; Huang L; Kong J; Zhang X
J Virol Methods; 2008 Jun; 150(1-2):1-6. PubMed ID: 18406475
[TBL] [Abstract][Full Text] [Related]
30. The Carboxyl Terminus of the Porcine Circovirus Type 2 Capsid Protein Is Critical to Virus-Like Particle Assembly, Cell Entry, and Propagation.
Zhan Y; Yu W; Cai X; Lei X; Lei H; Wang A; Sun Y; Wang N; Deng Z; Yang Y
J Virol; 2020 Apr; 94(9):. PubMed ID: 32075927
[TBL] [Abstract][Full Text] [Related]
31. Immunogenicity of adenovirus vaccines expressing the PCV2 capsid protein in pigs.
Li D; Du Q; Wu B; Li J; Chang L; Zhao X; Huang Y; Tong D
Vaccine; 2017 Aug; 35(36):4722-4729. PubMed ID: 28755834
[TBL] [Abstract][Full Text] [Related]
32. Enhanced Th1-biased immune efficacy of porcine circovirus type 2 Cap-protein-based subunit vaccine when coadministered with recombinant porcine IL-2 or GM-CSF in mice.
Wang Y; Lu Y; Liu D; Wei Y; Guo L; Wu H; Huang L; Liu J; Liu C
Appl Microbiol Biotechnol; 2015 Feb; 99(3):1155-63. PubMed ID: 25487886
[TBL] [Abstract][Full Text] [Related]
33. Construction and immunogenicity of recombinant adenovirus expressing the capsid protein of porcine circovirus 2 (PCV2) in mice.
Wang X; Jiang W; Jiang P; Li Y; Feng Z; Xu J
Vaccine; 2006 Apr; 24(16):3374-80. PubMed ID: 16524646
[TBL] [Abstract][Full Text] [Related]
34. Nanovaccine Confers Dual Protection Against Influenza A Virus And Porcine Circovirus Type 2.
Ding P; Jin Q; Chen X; Yang S; Guo J; Xing G; Deng R; Wang A; Zhang G
Int J Nanomedicine; 2019; 14():7533-7548. PubMed ID: 31571862
[TBL] [Abstract][Full Text] [Related]
35. Porcine reproductive and respiratory syndrome virus as a vector: immunogenicity of green fluorescent protein and porcine circovirus type 2 capsid expressed from dedicated subgenomic RNAs.
Pei Y; Hodgins DC; Wu J; Welch SK; Calvert JG; Li G; Du Y; Song C; Yoo D
Virology; 2009 Jun; 389(1-2):91-9. PubMed ID: 19423145
[TBL] [Abstract][Full Text] [Related]
36. Immunogenicity of porcine circovirus type 2 capsid protein targeting to different subcellular compartments.
Fan H; Xiao S; Tong T; Wang S; Xie L; Jiang Y; Chen H; Fang L
Mol Immunol; 2008 Feb; 45(3):653-60. PubMed ID: 17709139
[TBL] [Abstract][Full Text] [Related]
37. Immunogenicity and immunoprotection of porcine circovirus type 2 (PCV2) Cap protein displayed by Lactococcus lactis.
Li PC; Qiao XW; Zheng QS; Hou JB
Vaccine; 2016 Jan; 34(5):696-702. PubMed ID: 26372858
[TBL] [Abstract][Full Text] [Related]
38. Porcine MKRN1 Modulates the Replication and Pathogenesis of Porcine Circovirus Type 2 by Inducing Capsid Protein Ubiquitination and Degradation.
Wang T; Du Q; Wu X; Niu Y; Guan L; Wang Z; Zhao X; Liu SL; Tong D; Huang Y
J Virol; 2018 Jun; 92(11):. PubMed ID: 29514908
[TBL] [Abstract][Full Text] [Related]
39. Generation and immunogenicity of a recombinant pseudorabies virus expressing cap protein of porcine circovirus type 2.
Song Y; Jin M; Zhang S; Xu X; Xiao S; Cao S; Chen H
Vet Microbiol; 2007 Jan; 119(2-4):97-104. PubMed ID: 17005335
[TBL] [Abstract][Full Text] [Related]
40. Markedly different immune responses and virus kinetics in littermates infected with porcine circovirus type 2 or porcine parvovirus type 1.
Opriessnig T; Gerber PF; Matzinger SR; Meng XJ; Halbur PG
Vet Immunol Immunopathol; 2017 Sep; 191():51-59. PubMed ID: 28895867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
